Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 3Phase NA 1

Status

Unknown 5Recruiting 4Completed 2Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1NET 1Endocrine 1

Conditions

Neuroendocrine Tumors 1Neoplasms 1Lung Neoplasms 1177Lu-EB-FAPI 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × 68Ga-FAPI × Clear all
NCT07132645 2025-09-23

An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT05034146 2025-06-05

68Ga-FAPI PET/CT in Malignant Tumors

Zhongnan Hospital

Phase NA Recruiting
500 enrolled
Tumor-Agnostic

Neoplasms

NCT05400967 2024-09-19

Diagnosis of Metastatic Tumors on 68Ga-FAPI PET-CT and Radioligand Therapy with 177Lu-EB-FAPI

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Recruiting
10 enrolled

177Lu-EB-FAPI

NCT05543954 2024-07-05

68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Recruiting
60 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡